Cost-Effectiveness of Treating Advanced Progressive Pancreatic Neuroendocrine Tumor Patients With Everolimus Versus Sunitinib In Sweden
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1182
https://www.valueinhealthjournal.com/article/S1098-3015(15)01239-5/fulltext
Title :
Cost-Effectiveness of Treating Advanced Progressive Pancreatic Neuroendocrine Tumor Patients With Everolimus Versus Sunitinib In Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01239-5&doi=10.1016/j.jval.2015.03.1182
First page :
A204
Section Title :
Cancer
Open access? :
No
Section Order :
643